A detailed history of Dark Forest Capital Management LP transactions in Myriad Genetics Inc stock. As of the latest transaction made, Dark Forest Capital Management LP holds 56,372 shares of MYGN stock, worth $448,157. This represents 0.01% of its overall portfolio holdings.

Number of Shares
56,372
Holding current value
$448,157
% of portfolio
0.01%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$3.84 - $8.84 $216,468 - $498,328
56,372 New
56,372 $299,000
Q3 2022

Nov 14, 2022

BUY
$18.21 - $27.88 $9,177 - $14,051
504 New
504 $10,000
Q2 2022

Aug 15, 2022

SELL
$16.45 - $25.88 $5,083 - $7,996
-309 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$22.67 - $28.01 $2,085 - $2,576
-92 Reduced 22.94%
309 $8,000
Q4 2021

Feb 11, 2022

BUY
$24.13 - $32.63 $9,676 - $13,084
401 New
401 $11,000
Q3 2021

Nov 12, 2021

SELL
$29.97 - $36.66 $0 - $0
0 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$25.39 - $32.61 $0 - $0
0 New
0 $0

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $641M
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.